Drugs targeting SCD1 have shown promising effects in mice to prevent Parkinson′s disease, blunt weight gain, improve glucose tolerance, promote sebaceous gland atrophy, protect against fatty liver disease, and inhibit cancer cells [65,72]. Here, SCD is linked to fatty liver disease.